In this file
Curex’s allergy service and GLP-1 service should be evaluated as separate programs. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
Curex’s main site is strongly associated with allergy care, but it also has a dedicated GLP-1 offer. Pricing, insurance statements, and service benefits from the allergy program should not be carried into the weight-management comparison. Begin on the relevant program page and identify its medical and pharmacy arrangements.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The GLP-1 page advertises a first-month semaglutide offer from $49 and tirzepatide from $149, alongside a general starting figure of $199 per month and no membership fee. Ask for the undiscounted renewal price for the actual product. Promotional figures from another Curex service do not establish this plan’s cost.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
The page promotes cancellation and a conditional money-back offer. Request the complete conditions, eligibility requirements, submission process, and order cutoff before relying on that promise. A refund for clinical ineligibility is different from an outcome-based claim or cancellation after medication has been dispensed.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
The GLP-1 page identifies compounded medications and says Curex does not offer the named branded medicines referenced in its disclaimer. Readers should therefore not interpret familiar brand references or ingredient comparisons as a promise to receive those approved products.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
Curex’s published contact number is (857) 240-1080.
Specify the GLP-1 program; Curex also offers allergy care with different terms.
Start from the official Curex website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
What is the ongoing price of my GLP-1 preparation, and which exact conditions apply to the refund promise shown on this program page?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Insurance Coverage | Curex ↗Provider-published information · Checked September 22, 2026
- Curex GLP-1 ↗Provider-published information · Checked September 22, 2026
- Curex: Allergy Care & GLP-1 ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026